DeciBio Newsletters - Archives
See below for our most recent newsletters.
join our mailing list
Big Data & AI In Healthcare: Google Makes A Hosted Repository Of Public Datasets For Covid Research, Using ML To Grade Brain Tumor Severity
Liquid Biopsy Weekly: Stanford team announces new lung cancer detection assay
DTx first to clear new FDA pathway | Wearables fight COVID
Big Data & AI In Healthcare: Differentiating COVID-19 From Other Conditions And Predicting Tumor Sensitivity To Various Therapies Using CT Scans
Liquid Biopsy Weekly: QIAGEN developing NGS tests and a multi-modal workflow using liquid samples
Is COVID Dx production scaling quickly enough?
Big Data & AI In Healthcare: Baidu's Approach To Helping Control COVID-19, USARad's Teleradiology Approach To Diagnosing COVID-19
Liquid Biopsy Weekly: Cell-Free Microbial Could Play a Part in Cancer Diagnosis
Digital health takes on COVID-19
Big Data & AI In Healthcare: Deployment Of AI For Rapid Stroke Diagnosis, Automated CT Biomarkers Predict Cardiovascular Events And Mortality
Liquid Biopsy Weekly: Spotlight on JAMA paper using miRNA signatures to distinguish lung cancer patients
HHS interop rules finalized | New pharma-digital partnerships | FitBit in A-Fib
New Apple trial | Why 5G matters | Telehealth in 2020
Liquid Biopsy Weekly: Exciting research for glioblastoma, prostate and NSCLC; Developing geographies may leapfrog tissue biopsy to liquid biopsy
Big Data & AI In Healthcare: Radiation-Free AI Tool For Breast Cancer Detection, Proscia Releases Findings On Use Of DermAI In Real Lab Environments
Liquid Biopsy Weekly: Resolution Bio and Labcorp partner to commercialize lung ctDNA assay; continued interest in CTCs for prognosis and monitoring
Big Data & AI In Healthcare: MIT Researchers Identify New Antibiotic Via ML Algorithm, SPHCC & Yitu Develop AI Chest CT Evaluation System for COVID-19
Can big Dx repurpose Theranos' retail model?
Big Data & AI In Healthcare: ORNL Researchers Create "Multitasking" AI Tool For Extracting Cancer Data, AI Predicts Heart Attack Risk From Cardiac MRI
Liquid Biopsy Weekly: GRAIL initiates multi-center, interventional PATHFINDER study, FMI and Natera with key partnerships